-
Track & Monitor
Covid-19 in pharma: synthetic COVID vaccines
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the pharma industry’s synthetic COVID vaccines segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Thematic Analysis
Impact of Inflation on the Healthcare Sector, H2 2023 – Thematic Intelligence
Impact of Inflation on the Healthcare Sector Overview The wide availability of COVID-19 vaccines allowed economies and societies to safely reopen. However, factors such as supply-demand imbalance, inflation, recession prospects, market volatility, and geopolitical tensions and conflicts are hampering the economic recovery and growth prospects. These factors will have a reciprocal impact on healthcare services as well in 2024. The Impact of Inflation on the Healthcare Sector, H2 2023 report assesses inflation's impact on the treatment of patients and identifies...
-
Thematic Analysis
State of the Biopharmaceutical Industry in 2024 – Thematic Intelligence
Accessing in-depth insights from the ‘State of the Biopharmaceutical Industry’ report will help you in: Examining the current attitudes of business leaders toward the emerging trends impacting the biopharmaceutical industry in the next 12 months. Benchmarking the impact of major themes on the biopharmaceutical industry in 2024, including emerging technologies, regulatory trends, macroeconomic trends, and industry trends. Identifying the most impactful anticipated regulatory approvals and drug launches in the industry in 2024, learning about top-selling drugs (2023 vs 2024), and obtaining...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tocilizumab Biosimilar in Polyarticular Juvenile Idiopathic Arthritis (PJIA)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tocilizumab Biosimilar in Polyarticular Juvenile Idiopathic Arthritis (PJIA) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tocilizumab Biosimilar in Polyarticular Juvenile Idiopathic Arthritis (PJIA)...
-
Product Insights
Transdermal Drug Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Transdermal Drug Delivery Pipeline Market Report Overview Transdermal drug delivery devices are medicated adhesive patches placed on the skin to deliver a specific dose of medication through the skin into the bloodstream. The Transdermal Drug Delivery pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tertomotide in Progressive Supranuclear Palsy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Tertomotide in Progressive Supranuclear Palsy Drug Details: Tertomotide hydrochloride (Riavax) is a peptide vaccine. It...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Covid/Influenza Combination Vaccine in Seasonal Influenza
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Covid/Influenza Combination Vaccine in Seasonal Influenza Drug Details:ICC vaccine is under development for the prevention of seasonal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Jaktinib Hydrochloride in Ankylosing Spondylitis (Bekhterev’s Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Jaktinib Hydrochloride in Ankylosing Spondylitis (Bekhterev's Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Jaktinib Hydrochloride in Ankylosing Spondylitis (Bekhterev's Disease) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – InCVAX in Non-Small Cell Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. InCVAX in Non-Small Cell Lung Cancer Drug Details: inCVAX is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – InCVAX in Colorectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. InCVAX in Colorectal Cancer Drug Details: inCVAX is under development for the treatment of solid...